Skip to content

Cytokinetics CYTK Capital investments accrued but not yet paid

Capital investments accrued but not yet paid at other companies

BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$11.2M+151%
TKO Group Holdings logo
TKO Group HoldingsTKO
$10M+211%
Amkor Technology logo
Amkor TechnologyAMKR
$243.54M+97.7%
SBA Communications logo
SBA CommunicationsSBAC
$11.17M-27.5%
Sun Communities logo
Sun CommunitiesSUI
American Healthcare REIT logo
American Healthcare REITAHR

Other financials

Income statement

See full
Revenue$19.4M+1,126%
Operating income-$183.6M-18.0%
Net income-$206.0M-27.7%
EPS (diluted)-$1.67-22.8%

Balance sheet

See full
Cash & equivalents$129.8M+76.2%
Total debt$418.2M+75.8%
Total equity-$826.6M-210%
Total assets$1.3B+0.7%

Cash flow

See full
Operating cash flow-$145.5M-10.5%
CapEx$5.9M+4.7%
Free cash flow-$151.4M-10.3%

Valuation

See full
Market cap$10.7B+70.6%
Enterprise value$10.98B+70.7%
P/S101.1×-225×

Profitability

See full
Operating margin-605.1%-268pp
Net margin-784%-337pp
FCF margin-518.8%-223pp

Returns & leverage

See full
Return on equity-337.6%
Debt / equity2.2×
Current ratio4.2×-1.8×

Where this comes from

Reported directly by Cytokinetics in its filing.

Tagged under the XBRL concept us-gaap:CapitalExpendituresIncurredButNotYetPaid.

The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cytokinetics's capital investments accrued but not yet paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cytokinetics's capital investments accrued but not yet paid?
Cytokinetics (CYTK) reported capital investments accrued but not yet paid of $4.19M in Q1 2026.
How has Cytokinetics's capital investments accrued but not yet paid changed year-over-year?
Cytokinetics's capital investments accrued but not yet paid increased by 180.2% year-over-year, from $1.49M to $4.19M.